ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

St Jude Medical: Early Results From Riata Lead Evaluation Consistent With Other Studies

By Melodie Warner St. Jude Medical Inc. (STJ) said early results from the Riata lead evaluation study indicate externalized conductors occur less frequently in thinner leads and the rates were consistent with other published studies. The medical-device company voluntarily stopped selling its Riata and Riata ST silicone defibrillation leads in December 2010 following reports of wires wearing through their silicone covering. The latest study's Phase 1 results found that externalized conductors--or the appearance on x-ray or fluoroscopy of conductors outside of the lead body--occurred in 9.3% of the smaller-diameter Riata ST 7F leads in the study, and in 24% of the larger-diameter Riata 8F leads. The study enrolled 724 patients at 20 sites in the U.S. and Canada. An additional 51 patients were enrolled at three sites in Japan and those results are awaiting final adjudication and will be reported at a later date. "The rates of externalized conductors in this study are consistent with other published studies involving fluoroscopic screening of patients with Riata leads," said Mark Carlson, chief medical officer and senior vice president of clinical affairs for the St. Jude Medical Cardiac Rhythm Management Division. "This study also reinforces that externalized conductors are more prevalent in larger-diameter Riata leads." The study will continue to evaluate the performance of Riata leads over the next two years to determine how they function over time. The company said in other clinical studies, the majority of leads with an externalized conductor continued to function normally. St. Jude Medical said its independent leads medical advisory board has reviewed the results and recommends no changes to existing patient management recommendations. The company said it will now focus on collecting longer-term data in the second phase of this study in order to provide physicians "timely and relevant clinical data to best support their patient management decisions." In April, St. Jude said it was seeking a retraction of a study published in the February edition of the Heart Rhythm Journal medical periodical that found heart-defibrillator wires made by the company were responsible for at least 20 deaths, citing inaccurate facts and biased analysis. The study also purported the deaths allegedly caused by Riata malfunctions were about nine times greater than a competing lead called the Quattro Secure made by Medtronic Inc. (MDT). Write to Melodie Warner at melodie.warner@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
06/16/201416:52:09MARKET SNAPSHOT: U.S. Stocks Inch Up; Iraq Concerns Weigh
06/16/201412:24:00LONDON MARKETS: U.K. Stocks Slip For Second Day As Pound Rallies
06/16/201412:19:39EUROPE MARKETS: European Stocks Bruised By Iraq Tensions
06/16/201411:20:49MARKET SNAPSHOT: U.S. Stocks Inch Higher After Upbeat Data
06/15/201422:22:38Medical Merger Part of 'Tax Inversion' Wave -- Update
06/05/201407:09:39European Markets Await ECB Policy Announcement
06/04/201418:01:01Medtronic Mulls Offer for Smith & Nephew -Bloomberg
05/29/201409:44:09U.S. Hot Stocks: Hot Stocks to Watch
05/28/201416:50:07Medtronic to Pay $9.9 Million to Resolve Improper-Payments Allegations
05/28/201416:37:40Medtronic to Pay $9.9 Million to Resolve Improper-Payments Allegations...
05/20/201409:05:06Medtronic Settles Edwards Lifesciences Patent Suit, Profit Drops--Update
05/20/201408:44:49Correction to Medtronic Settles Patent Dispute With Edwards...
05/20/201408:30:33Metronic Settles Patent Dispute With Edwards, Earnings Drop
05/19/201408:50:12MARKET SNAPSHOT: Only A 'black Swan' Will Bring Back Stock Volatility
05/08/201418:25:15Boston Scientific Subpoenaed Over Defibrillator Devices
05/06/201417:29:52Medtronic to Post Charge Related to Bone Graft Suits
04/14/201416:42:11MARKET SNAPSHOT: Stocks Rebound; Nasdaq Erases Late Swoon
04/14/201415:49:35MARKET SNAPSHOT: Stocks Trim Gains; Nasdaq Turns Negative
04/14/201415:21:40CORRECT: Preliminary Injunction Bars Medtronic From Selling CoreValve
04/14/201411:56:03MARKET SNAPSHOT: Stocks Rebound On Retail Sales, Citi Results

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad